Cytek Biosciences, Inc. CTKB Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s operating lease ROU assets?
- Cytek Biosciences, Inc. (CTKB) reported operating lease ROU assets of 4.5% in Q1 2026.
- How has Cytek Biosciences, Inc.'s operating lease ROU assets changed year-over-year?
- Cytek Biosciences, Inc.'s operating lease ROU assets decreased by 100.0% year-over-year, from 986,900,000% to 4.5%.
- What is the long-term trend for Cytek Biosciences, Inc.'s operating lease ROU assets?
- Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s operating lease ROU assets has grown at a -99.3% compound annual growth rate (CAGR), from 1,460,000,000% to 4.5%.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.